Literature DB >> 21790923

Low positive predictive value of the ABCD2 score in emergency department transient ischaemic attack diagnoses: the South Western Sydney transient ischaemic attack study.

D Ghia1, P Thomas, D Cordato, D Epstein, R G Beran, C Cappelen-Smith, N Griffith, I Hanna, A McDougall, S J Hodgkinson, J M Worthington.   

Abstract

BACKGROUND: The ABCD(2) stroke risk score is recommended in national guidelines for stratifying care in transient ischaemic attack (TIA) patients, based on its prediction of early stroke risk. We had become concerned about the score accuracy and its clinical value in modern TIA cohorts.
METHODS: We identified emergency department-diagnosed TIA at two hospitals over 3 years (2004-2006). Cases were followed for stroke occurrence and ABCD(2) scores were determined from expert record review. Sensitivity, specificity and positive predictive values (PPV) of moderate-high ABCD(2) scores were determined.
RESULTS: There were 827 indexed TIA diagnoses and record review was possible in 95.4%. Admitted patients had lower 30-day stroke risk (n = 0) than discharged patients (n = 7; 3.1%) (P < 0.0001). There was no significant difference in proportion of strokes between those with a low or moderate-high ABCD(2) score at 30 (1.2 vs 0.8%), 90 (2.0 vs 1.9%) and 365 days (2.4 vs 2.4%) respectively. At 30 days the sensitivity, specificity and PPV of a moderate-high score were 57% (95% confidence interval (CI) 25.0-84.2), 32.2% (95% CI 29.1-35.6) and 0.75% (95% CI 0.29-1.91) respectively.
CONCLUSIONS: Early stroke risk was low after an emergency diagnosis of TIA and significantly lower in admitted patients. Moderate-high ABCD(2) scores did not predict early stroke risk. We suggest local validation of ABCD(2) before its clinical use and a review of its place in national guidelines.
© 2011 The Authors. Internal Medicine Journal © 2011 Royal Australasian College of Physicians.

Entities:  

Mesh:

Year:  2012        PMID: 21790923     DOI: 10.1111/j.1445-5994.2011.02564.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  6 in total

1.  At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction.

Authors:  Paolo Fusar-Poli; Marco Cappucciati; Grazia Rutigliano; Frauke Schultze-Lutter; Ilaria Bonoldi; Stefan Borgwardt; Anita Riecher-Rössler; Jean Addington; Diana Perkins; Scott W Woods; Thomas H McGlashan; Jimmy Lee; Joachim Klosterkötter; Alison R Yung; Philip McGuire
Journal:  World Psychiatry       Date:  2015-10       Impact factor: 49.548

Review 2.  ABCD2 score and secondary stroke prevention: meta-analysis and effect per 1,000 patients triaged.

Authors:  Joanna M Wardlaw; Miriam Brazzelli; Francesca M Chappell; Hector Miranda; Kirsten Shuler; Peter A G Sandercock; Martin S Dennis
Journal:  Neurology       Date:  2015-07-01       Impact factor: 9.910

3.  Perfusion deficits detected by arterial spin-labeling in patients with TIA with negative diffusion and vascular imaging.

Authors:  X J Qiao; N Salamon; D J J Wang; R He; M Linetsky; B M Ellingson; W B Pope
Journal:  AJNR Am J Neuroradiol       Date:  2013-05-30       Impact factor: 3.825

4.  Risk of Subsequent Stroke Among Patients Receiving Outpatient vs Inpatient Care for Transient Ischemic Attack: A Systematic Review and Meta-analysis.

Authors:  Shima Shahjouei; Jiang Li; Eric Koza; Vida Abedi; Alireza Vafaei Sadr; Qiushi Chen; Ashkan Mowla; Paul Griffin; Annemarei Ranta; Ramin Zand
Journal:  JAMA Netw Open       Date:  2022-01-04

5.  From Inpatient to Ambulatory Care: The Introduction of a Rapid Access Transient Ischaemic Attack Service.

Authors:  Mohana Maddula; Laura Adams; Jonathan Donnelly
Journal:  Healthcare (Basel)       Date:  2018-06-01

Review 6.  Clinical Risk Score for Predicting Recurrence Following a Cerebral Ischemic Event.

Authors:  Durgesh Chaudhary; Vida Abedi; Jiang Li; Clemens M Schirmer; Christoph J Griessenauer; Ramin Zand
Journal:  Front Neurol       Date:  2019-11-12       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.